Chronic Gastric Electrical Stimulation for Gastroparesis Reduces the Use of Prokinetic and/or Antiemetic Medications and the Need for Hospitalizations
To investigate the effect of chronic gastric electrical stimulation (GES) on the daily use of prokinetics and antiemetics, hospitalizations, total symptom score (TSS), SF-36 status for health-related quality of life (HQOL), and gastric emptying of a solid meal, we evaluated 37 gastroparetic patients preoperatively and 1 year after undergoing GES implant. Prokinetic and antiemetic use was significantly reduced. Of 27 patients on at least one prokinetic at baseline, 8 were off at 1 year. Twenty-six patients requiring antiemetics before surgery decreased to 17. Mean TSS was significantly reduced and the reduction for patients off medications was significantly better than for patients still on medications. Overall SF-36 scores for HQOL were significantly improved, and patients off antiemetics had a significantly higher HQOL score than for patients on antiemetics at 1 year. Hospitalizations decreased from 50 ± 10 days for the year prior to GES therapy to 14± 3 days (P < 0.05). However, gastric emptying was not significantly improved. Conclusions are as follows. (1) Chronic GES significantly reduced the use of prokinetic/antiemetic medications and the need for hospitalization in gastropraretic patients, whose clinical and quality of life outcomes also significantly improved (2) These data provide evidence of the positive economic impact of this new therapy on long-term clinical outcomes in gastroparetic patients not responding to standard medical therapy.
Key Wordsgastric electrical stimulation gastroparesis prokinetic medications antiemetic medications nausea and vomiting health-related quality of life
Unable to display preview. Download preview PDF.
- 4.Koch KL: Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus, a review of symptoms, pathophysiology, and treatment. Dig Dis Sci 44:1061–1075, 1994Google Scholar
- 11.Abell TL, Cutsem EV, Abrahamsson H, Huizinga JD, Kontruek JW, Galmiche JP, Voeller G, Filez L, Everts B, Waterfall WE, Domschke W, des Varanbes SB, Familoni BO, Bourgeois IM, Janssens J, Tougas G: Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion 66:204–212, 2002PubMedGoogle Scholar
- 13.McElhinney C, Sarosiek I, Lin Z, McCallum RW: Comparison of hospitalizations, medications, and quality of life in patients receiving gastric electrical stimulation (GES) therapy for severe gastroparesis. Gastroenterology 122:A–82, 2002 (abstract)Google Scholar
- 14.Soykan I, Sarodiek I, McCallum RW: The effect of chronic oral domperidone therapy on GI symptoms, gastric emptying and quality of life in patients with gastroparesis. Am J Gastrointerol 92:976–980, 1997Google Scholar
- 16.Abell TL, Hocking M, McCallum R, Koch K, Nowak T, Diabaise JK: LongDterm hospitalization outcomes and economic impact of gastric electrical stimulation (GES) in patients with drug refractory gastroparesis. Gastroenterology 120(5):A–408, 2001 (abstract)Google Scholar
- 18.Tougas G, Eaker EY, Abell TL, Abrahamsson H, Boivin M, Chen J, Hocking MP, Quigley EMM, Koch K, Tokayer AZ, Stanghellini V, Chen Y, Huizinga JD, Ryden J, Bourgeois I, McCallum RW: Assessment of gastric emptying using a low fat meal: Establishment of international control values. Am J Gastroenterol 95(6):1456–1462, 2000PubMedGoogle Scholar
- 19.Ware JE Jr: SF–36 Health Survey, manual and interpretation guide. Boston, MA, Health Institute, New England Medical Center, 1993Google Scholar
- 20.Ware JE, Kosinski M, Keller SD: SFD36 Physical and Mental Health Summary Scales: A userõs manual. Boston, MA, Health Assessment Lab, 1994Google Scholar
- 23.Tack J, Coulie B, Van Cutsem E, Ryden J, Janssens KU: The influence of gastric electrical stimulation on proximal gastric motor and sensory function in severe idiopathic gastroparesis. Gastroenterology 116:G4733, 1999Google Scholar